<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00740909</url>
  </required_header>
  <id_info>
    <org_study_id>2008P000565</org_study_id>
    <nct_id>NCT00740909</nct_id>
  </id_info>
  <brief_title>Cognitive Behavioral Therapy for Trichotillomania</brief_title>
  <acronym>CBT for TTM</acronym>
  <official_title>Cognitive Behavioral Therapy for Trichotillomania</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Emory University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <brief_summary>
    <textblock>
      This study aims to develop a comprehensive Cognitive Behavioral Therapy protocol for adult&#xD;
      patients with Trichotillomania that emphasizes relapse prevention and that addresses comorbid&#xD;
      affective symptoms, as well. The study will compare the efficacy of CBT with a minimal&#xD;
      attention control (MAC)condition. We hypothesize that outcome at post-treatment, 3-month, and&#xD;
      6-month follow-up will be better for the CBT vs. MAC condition including higher responder&#xD;
      rates and greater reduction in hair pulling severity.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to assess the efficacy of cognitive behavioral therapy for&#xD;
      patients with trichotillomania.&#xD;
&#xD;
      Following entry into the study, subjects will be randomized into a cognitive behavioral&#xD;
      therapy (CBT) or a minimized attention control (MAC) condition. Subjects will be assessed&#xD;
      with the Acceptance and Action Questionnaire (AAQ), the Affective Regulation Rating (ARR),&#xD;
      the Barratt Impulsivity Scale (BIS-11), Beck Depression Inventory (BDI), Beck Anxiety&#xD;
      Inventory (BAI), Clinical Global Impressions Scale (CGI), the Difficulties in Emotion&#xD;
      Regulation Scale (DERS), Hair Pulling Scale (HPS), Trichotillomania (TTM) Impact Scale,&#xD;
      Psychiatric Institute Trichotillomania Scale (PITS), National Institute of Mental Health&#xD;
      Trichotillomania Severity Scale(NIMH-TSS), the Generalized Expectancy for Negative Mood&#xD;
      Regulation Scale (NMR), The Milwaukee Inventory for Subtypes of Trichotillomania- Adult&#xD;
      Version (MIST-A), the Positive and Negative Affect Scale (PANAS), the Quality of Life&#xD;
      Inventory (QOLI), the Readiness to Change Hairpulling Behavior (RCHPB), the Self-Esteem Scale&#xD;
      (SES), the Skin Picking Scale (SPS) and the Scales of Psychological Well-Being (SPWB).&#xD;
      Subject randomization to a treatment arm will be determined by a random number generator.&#xD;
&#xD;
      Subject change scores will be assessed for the above scales.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2008</start_date>
  <completion_date type="Actual">January 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Massachusetts General Hospital Hair Pulling Scale (MGHHPS)</measure>
    <time_frame>Baseline, weekly visits, follow-up</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>NIMH Trichotillomania Severity Scale (NIMH-TSS)</measure>
    <time_frame>Baseline, weekly visits, follow-up</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>NIMH Trichotillomania Impairment Scale (NIMH-TIS)</measure>
    <time_frame>Baseline, weekly visits, follow-up</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">38</enrollment>
  <condition>Trichotillomania</condition>
  <arm_group>
    <arm_group_label>MAC</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Minimal Attention Control</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CBT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cognitive Behavioral Therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive Behavioral Therapy</intervention_name>
    <description>A therapy designed to help patients with response prevention skills.</description>
    <arm_group_label>CBT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  primary DSM-IV diagnosis of TTM&#xD;
&#xD;
          -  outpatients who are 18 or older&#xD;
&#xD;
          -  a minimum MGHHPS total scale score of 10&#xD;
&#xD;
          -  a minimum TTM symptom duration of 1 year with no significant remissions (as defined by&#xD;
             complete abstinence of hair extraction for a 2-week period during the prior 6 months)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  presence of a serious psychiatric condition including mental retardation, psychosis,&#xD;
             pervasive developmental disorder, organic mental disorders, manic episode, ADHD,&#xD;
             suicidality, lifetime alcohol or substance dependence, or alcohol or substance abuse&#xD;
             within the past 3 months&#xD;
&#xD;
          -  presence of a serious medical condition that would limit ability to routinely attend&#xD;
             sessions and complete homework assignments&#xD;
&#xD;
          -  individual or group psychotherapy (not addressing TTM) that has not been ongoing for&#xD;
             the past 3 months and/or without intent to continue same treatment during study&#xD;
             tenure)&#xD;
&#xD;
          -  previous CBT for TTM&#xD;
&#xD;
          -  involvement in other treatment for TTM&#xD;
&#xD;
          -  psychotropic medication that has not been stable for 3 months prior to study&#xD;
             enrollment and/or without intent to continue same medication regimen during study&#xD;
             tenure)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nancy Keuthen, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <study_first_submitted>August 21, 2008</study_first_submitted>
  <study_first_submitted_qc>August 22, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 25, 2008</study_first_posted>
  <last_update_submitted>June 19, 2012</last_update_submitted>
  <last_update_submitted_qc>June 19, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 20, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Nancy J. Keuthen</investigator_full_name>
    <investigator_title>Nancy J. Keuthen, Ph.D</investigator_title>
  </responsible_party>
  <keyword>Trich</keyword>
  <keyword>Hair Pulling</keyword>
  <keyword>Cognitive Behavioral Therapy</keyword>
  <keyword>Behavioral Therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Trichotillomania</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

